Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights
11/20/2009 10:32:53 AM
More...
|
Omeros Corporation, First U.S. Biotech IPO Since February 2008, Sees Shares Drop 13 Percent in First Day
10/9/2009 7:07:32 AM
More...
|
Omeros Corporation Raises $68.2M in Washington's First IPO in Two Years
10/8/2009 6:49:49 AM
More...
|
Omeros Corporation Announces IPO of 6.8 Million Shares
9/18/2009 6:44:41 AM
More...
|
Omeros Corporation Moves Closer To IPO, Sets Price Goal
9/17/2009 7:59:51 AM
More...
|
Omeros Corporation Plans to Test Waters with First Washington IPO in Two Years, Sources Say
8/27/2009 7:08:13 AM
More...
|
Omeros Corporation Announces Positive Clinical Results of Phase 1/Phase 2 Trial of OMS302 for Use During Ophthalmologic Surgery
8/11/2009 6:40:39 AM
More...
|
Omeros Corporation Appoints New Vice President of Clinical Development
8/5/2009 9:01:54 AM
More...
|
Omeros Corporation Receives $3.1 Million Milestone Payment from The Stanley Medical Research Institute for Schizophrenia Program
1/28/2009 11:17:24 AM
More...
|
Omeros Corporation Awarded Grant from The Michael J. Fox Foundation to Evaluate Novel Parkinson's Disease Target
1/7/2009 8:37:51 AM
More...
|
|